tradingkey.logo

InfuSystem Holdings Inc

INFU
View Detailed Chart
7.720USD
+0.150+1.98%
Close 02/06, 16:00ETQuotes delayed by 15 min
156.93MMarket Cap
29.15P/E TTM

InfuSystem Holdings Inc

7.720
+0.150+1.98%
Intraday
1m
30m
1h
D
W
M
D

Today

+1.98%

5 Days

-6.54%

1 Month

-11.97%

6 Months

+7.67%

Year to Date

-13.94%

1 Year

-4.10%

View Detailed Chart

Key Insights

InfuSystem Holdings Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 62 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 14.20.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

InfuSystem Holdings Inc's Score

Industry at a Glance

Industry Ranking
62 / 205
Overall Ranking
171 / 4521
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

InfuSystem Holdings Inc Highlights

StrengthsRisks
InfuSystem Holdings, Inc. is a national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. Its segments include Patient Services and Device Solutions. Its core service within its Patient Services segment is its Oncology Business. Patient Services supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its Device Solutions segment’s core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment, sell treatment-related consumables, and provide biomedical recertification, maintenance and repair services for oncology practices and other healthcare site settings, including, home care and home infusion providers and others.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 22.70% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 134.86M.
Undervalued
The company’s latest PE is 29.15, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 15.52M shares, decreasing 11.77% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 981.58K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 2.54.

Analyst Rating

Based on 5 analysts
Buy
Current Rating
14.200
Target Price
+87.58%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

InfuSystem Holdings Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

InfuSystem Holdings Inc Info

InfuSystem Holdings, Inc. is a national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. Its segments include Patient Services and Device Solutions. Its core service within its Patient Services segment is its Oncology Business. Patient Services supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its Device Solutions segment’s core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment, sell treatment-related consumables, and provide biomedical recertification, maintenance and repair services for oncology practices and other healthcare site settings, including, home care and home infusion providers and others.
Ticker SymbolINFU
CompanyInfuSystem Holdings Inc
CEOLachance (Carrie A)
Websitehttps://ir.infusystem.com/
KeyAI